Daily MCQs for UPSC Preparation » Daily MCQs 15 September

Daily MCQs 15 September

Q 1. Who among the following is known as the “Father of Indian Archaeology”?

  1. Alexander Cunningham

  2. Gordon Child

  3. Mortimer Wheeler

  4. John Marshall

Answer: (a)

Recently, Braj Basi Lal, the former director general of the Archaeological Survey of India (1968-1972) and a Padma Vibhushan awardee, passed away.

Option (a) is correct: Archaeological Survey of India (ASI), under the Ministry of Culture, is the premier organisation for the archaeological research and protection of the cultural heritage of the nation. It administers ancient monuments, archaeological sites and remains of national importance.

Alexander Cunnigham, the first Director-General of the Archaeological Survey of India is often called the father of Indian Archaeology. He was a British army engineer who later took an interest in the history and archaeology of India. Alexander noted that the amount of brick taken from the ancient site was enough to lay bricks for about 100 miles of the railway line between Lahore and Multan.

 

Q 2. Which of the following countries are members of the Group of Seven (G7)?

  1. Canada

  2. Germany

  3. Italy

  4. Japan

  5. Russia

Select the correct answer using the code given below:

  1. 1, 2 and 3 only

  2. 3, 4 and 5only

  3. 1, 2, 3 and 4 only

  4. 1, 2, 3, 4 and 5

Answer: (c)

The Group of Seven countries is working to cap the price of Russian oil in an attempt to limit Moscow’s ability to fund its invasion of Ukraine.

Option (c) is correct: Group of Seven (G7) is an intergovernmental organisation that was formed in 1975. The bloc meets annually to discuss issues of common interest like global economic governance, international security, and energy policy. The G7 countries are the UK, Canada, France, Germany, Italy, Japan and the US. The G7 does not have a formal charter or a secretariat. The presidency, which rotates among member countries each year, oversees setting the agenda. Sherpas, ministers, and envoys hammer out policy initiatives before the summit.

Q 3. Miyawaki’s method was recently mentioned in the news. It is associated with:

  1. Afforestation

  2. Crop rotation 

  3. Water harvesting method 

  4. Indigenous wastewater treatment

Answer: (a)

The Japanese “Miyawaki method” used in Kuharianwali village of Punjab in one acre of unused land has grown into a “forest” in less than a year. The village has become a trendsetter in expanding forest cover.

Option (a) is correct: Miyawaki is a technique pioneered by Japanese botanist Akira Miyawaki, that helps in Afforestation (building dense, native forests in a short time). In the Miyawaki technique, various native species of plants are planted close to each other so that the greens receive sunlight only from the top and grow upwards rather than sideways. As a result, the plantation becomes approximately 30 times denser, grows 10 times faster and becomes maintenance-free after a span of 3 years.

Miyawaki Method - Drishti IAS

Q 4. With reference to Chimeric Antigen Receptor (CAR)-T Cell T therapy, consider the following statements:

  1. CAR-T cells are a patient’s own immune cells that are genetically engineered in the laboratory to fight cancer.

  2. Immuno ACT along with Immuneel Therapeutics are two startups currently working to make CAR-T cell therapy available in India.

Which of the statements given above is/are correct?

  1. 1 only

  2. 2 only

  3. Both 1 and 2

  4. Neither I nor 2

Answer: (c)

Recently, researchers have said that India’s first indigenously developed Chimeric Antigen Receptor (CAR)-T Cell T therapy for specific types of cancer patients has shown promising results and could be the safest therapy in this category so far.

Statement 1 is correct: CAR-T cells are a patient’s own immune cells that are genetically engineered in the laboratory to fight cancer. CAR-T cell is a prospective therapy that has ushered in a new era of curing refractory and stubborn cancers. CAR T cell therapy is used as third or second-line treatment for patients with specific types of cancers of blood and lymph nodes. In India, those willing to undergo this treatment have to travel to other countries, mostly the US.

The therapy targets leukaemia and lymphoma. Leukaemia is cancer of blood-forming tissues, including bone marrow. Lymphoma is a cancer of the lymphatic system, which is part of the body’s germ-fighting network.

Statement 2 is correct: Immuno ACT along with Immuneel Therapeutics are two startups currently working to make CAR – T cell therapy available in India. Both of these companies have said the therapy would be available in the country at a fraction of the cost charged for the treatment in developed countries like the US where it can cost about Rs 2-3 crore.

Q 5. With reference to Ayushman Bharat Digital Mission, consider the following statements:

  1. National Health Authority (NHA) under the Ministry of Health and Family Welfare is the implementing Agency for Ayushman Bharat Digital Mission. 

  2. Under this, every citizen will now get a digital health ID and their health record will be digitally protected.

Which of the statements given above is/are correct?

  1. 1 only

  2. 2 only

  3. Both 1 and 2

  4. Neither I nor 2

Answer: (c)

The Union government’s healthcare spending dropped to 1.28 per cent of the Gross Domestic Product (GDP) in 2018-19 from the previous year’s figure of 1.35 per cent.

Statement 1 is correct: In September 2021, the Prime Minister of India launched the Ayushman Bharat Digital Mission. The mission will connect the digital health solutions of hospitals across the country with each other. The National Health Authority (NHA) under the Ministry of Health and Family Welfare is the implementing Agency for Ayushman Bharat Digital Mission.

Statement 2 is correct: Under this, every citizen will now get a digital health ID and their health record will be digitally protected. Health ID will be issued for every citizen that will also work as their health account. This health account will contain details of every test, every disease, the doctors visited, the medicines taken and the diagnosis. Health ID is free of cost and voluntary. It will help in doing analysis of health data and lead to better planning, budgeting and implementation for health programs.